Positive parietal cell antibodies indicate an autoimmune response against stomach parietal cells. This can reduce intrinsic factor and stomach acid, increasing risk of pernicious anemia, vitamin B12 deficiency, and chronic atrophic gastritis. It’s a marker—not a definitive diagnosis—so doctors usually check B12 and intrinsic factor antibodies, gastrin levels, and may perform endoscopy. Some people have antibodies without symptoms.

Parietal cell antibody positivity signals autoimmune gastritis; treatment targets consequences rather than clearing antibodies. Check and replace vitamin B12 (intramuscular or high‑dose oral), correct iron deficiency if present, and monitor CBC and B12 markers. Arrange periodic upper endoscopy for atrophic changes/neoplasia as advised, and screen for associated autoimmune conditions (for example, thyroid disease). Symptomatic care as needed.

A positive APCA (anti‑parietal cell antibody) test suggests an autoimmune attack on stomach parietal cells. It’s commonly associated with autoimmune (atrophic) gastritis, reduced intrinsic factor, and increased risk of vitamin B12 deficiency and pernicious anemia, and can occur with other autoimmune conditions. It’s not diagnostic alone; clinicians will usually check B12 and intrinsic factor antibodies, gastrin levels, and consider endoscopy and monitoring.

Autoimmune gastritis (autoimmune atrophic gastritis) is the condition that targets gastric parietal cells. Autoantibodies against parietal cells—and often intrinsic factor—lead to reduced acid secretion and impaired vitamin B12 absorption, which can cause pernicious anemia. It mainly affects the stomach’s corpus and fundus and often develops gradually with nonspecific early symptoms.

Parietal cells are damaged in autoimmune gastritis—including pernicious anemia—and by chronic Helicobacter pylori–associated gastritis, which can produce atrophic gastritis and parietal cell loss with hypochlorhydria and vitamin B12 deficiency. Chronic atrophy raises gastric cancer risk. Conversely, Zollinger–Ellison syndrome causes parietal cell hyperplasia and excessive acid secretion. Parietal cell autoantibodies mediate many autoimmune cases.

A positive antibody test generally means you were previously infected or vaccinated and have mounted an immune response. It does not confirm current infection or absolute protection against reinfection or transmission; antibody levels can decline over time. Continue following public-health guidance, consider vaccination or boosters if recommended, and discuss results with a clinician who can interpret timing, test type, and implications for your care.